Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2017 1
2019 1
2020 2
2021 5
2022 2
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Explainable 3D CNN based on baseline breast DCE-MRI to give an early prediction of pathological complete response to neoadjuvant chemotherapy.
Comes MC, Fanizzi A, Bove S, Didonna V, Diotiaiuti S, Fadda F, La Forgia D, Giotta F, Latorre A, Nardone A, Palmiotti G, Ressa CM, Rinaldi L, Rizzo A, Talienti T, Tamborra P, Zito A, Lorusso V, Massafra R. Comes MC, et al. Among authors: ressa cm. Comput Biol Med. 2024 Apr;172:108132. doi: 10.1016/j.compbiomed.2024.108132. Epub 2024 Mar 14. Comput Biol Med. 2024. PMID: 38508058 Free article.
Oncoplastic and reconstructive surgery in SENONETWORK Italian breast centers: lights and shadows.
Ghilli M, Lisa AVE, Salgarello M, Papa G, Rietjens M, Folli S, Curcio A, Ferrari G, Caruso F, Altomare V, Friedman D, De Santis MC, De Rose F, Meduri B, De Felice F, Marino L, Cucciarelli F, Montemezzi S, Panizza P, Belli P, Caumo F, Vinci V, De Santis G, Klinger M, Roncella M; Senonetwork working group. Ghilli M, et al. Breast. 2024 Feb;73:103601. doi: 10.1016/j.breast.2023.103601. Epub 2023 Nov 18. Breast. 2024. PMID: 38043223 Free PMC article.
Analyzing breast cancer invasive disease event classification through explainable artificial intelligence.
Massafra R, Fanizzi A, Amoroso N, Bove S, Comes MC, Pomarico D, Didonna V, Diotaiuti S, Galati L, Giotta F, La Forgia D, Latorre A, Lombardi A, Nardone A, Pastena MI, Ressa CM, Rinaldi L, Tamborra P, Zito A, Paradiso AV, Bellotti R, Lorusso V. Massafra R, et al. Among authors: ressa cm. Front Med (Lausanne). 2023 Feb 2;10:1116354. doi: 10.3389/fmed.2023.1116354. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36817766 Free PMC article.
A machine learning ensemble approach for 5- and 10-year breast cancer invasive disease event classification.
Massafra R, Comes MC, Bove S, Didonna V, Diotaiuti S, Giotta F, Latorre A, La Forgia D, Nardone A, Pomarico D, Ressa CM, Rizzo A, Tamborra P, Zito A, Lorusso V, Fanizzi A. Massafra R, et al. Among authors: ressa cm. PLoS One. 2022 Sep 19;17(9):e0274691. doi: 10.1371/journal.pone.0274691. eCollection 2022. PLoS One. 2022. PMID: 36121822 Free PMC article.
BRAFV600E;K601Q metastatic melanoma patient-derived organoids and docking analysis to predict the response to targeted therapy.
Porcelli L, Di Fonte R, Pierri CL, Fucci L, Saponaro C, Armenio A, Serratì S, Strippoli S, Fasano R, Volpicella M, Daprile R, Tommasi S, Ressa CM, Guida M, Azzariti A. Porcelli L, et al. Among authors: ressa cm. Pharmacol Res. 2022 Aug;182:106323. doi: 10.1016/j.phrs.2022.106323. Epub 2022 Jun 22. Pharmacol Res. 2022. PMID: 35752358 Free article.
15 results